Kelly K. Hunt, MD, on Current Thinking on Neoadjuvant Therapy for Advanced Breast Cancer

Posted: Tuesday, May 21, 2024

Kelly K. Hunt, MD, of The University of Texas MD Anderson Cancer Center, describes current thinking on the benefits of neoadjuvant therapy for patients with advanced and inoperable breast cancer, how this treatment approach may be used in the setting of early disease, how the residual cancer burden calculator is employed in clinical practice, and novel approaches now being investigated.

---